• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    TrueBlue downgraded by BMO Capital Markets with a new price target

    5/26/22 7:26:10 AM ET
    $TBI
    Professional Services
    Consumer Discretionary
    Get the next $TBI alert in real time by email
    BMO Capital Markets downgraded TrueBlue from Outperform to Market Perform and set a new price target of $20.00 from $36.00 previously
    Get the next $TBI alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TBI

    DatePrice TargetRatingAnalyst
    5/22/2023$18.00 → $20.00Market Perform → Outperform
    BMO Capital Markets
    5/26/2022$36.00 → $20.00Outperform → Market Perform
    BMO Capital Markets
    4/11/2022$38.00Buy
    Sidoti
    More analyst ratings